PREGABALIN by Novartis is clinical pharmacology: mechanism of action: pregabalin is a ligand of alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system. Approved for pain, clinical signs associated with chiari-like malformation, syringomyelia in dogs.
Drug data last refreshed 38m ago
Clinical Pharmacology: Mechanism of action: Pregabalin is a ligand of alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system. Pregabalin reduces the presynaptic calcium influx in neurons and there by the release of various neurotransmitters, including glutamate,…
Worked on PREGABALIN at Novartis? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
A Phase 2a Study Comparing the Efficacy, Safety and Tolerability of Pregabalin Eye Drops Comparing With Timolol Eye Drops in Adults With Glaucoma or High Eye Pressure.
Pharmacokinetics of Y-4 Tablets With Pregabalin Capsules and Riluzole Tablets in U.S. Healthy Participants
Efficacy and Safety of Pregabalin/Tizanidine vs. Pregabalin in Patients With Fibromyalgia
Pharmacokinetics of Y-4 Tablets With Pregabalin Capsules and Riluzole Tablets in Chinese Healthy Subject
Pharmacodynamic Study of 300mg Pregabalin vs Placebo in Healthy Male Adults